MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis

Acute myeloid leukemia (AML) is one of the most common hematological malignancies all around the world. MicroRNAs have been determined to contribute various cancers initiation and progression, including AML. Although microRNA-204 (miR-204) exerts anti-tumor effects in several kinds of cancers, its f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMB Rep
Päätekijät: Wang, Zhiguo, Luo, Hong, Fang, Zehui, Fan, Yanling, Liu, Xiaojuan, Zhang, Yujing, Rui, Shuping, Chen, Yafeng, Hong, Luojia, Gao, Jincheng, Zhang, Mei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Society for Biochemistry and Molecular Biology 2018
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6177501/
https://ncbi.nlm.nih.gov/pubmed/29764561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2018.51.9.036
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia